Analytical Data
-
基因名
EM1
- Application
-
别名
EM1；DXS552E；EMP55；55 kDa erythrocyte membrane Protein
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P27205
-
表达区间
1-34aa
-
氨基酸序列
AGSKSRSRSR SRSRSKSPAK SASPKSAASP RASR
-
分子量
3.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of EM1 recombinant protein is underpinned by the growing interest in its potential applications in biotechnology and medicine. EM1, a member of the emerging class of proteins with diverse biological functions, is primarily recognized for its role in cellular signaling and response mechanisms. The recombinant expression of EM1 allows for the detailed investigation of its structural and functional properties, facilitating an understanding of its implications in various physiological processes. Researchers aim to explore its therapeutic potential, particularly in disease models where EM1’s involvement has been implicated, such as in immune response modulation and cancer progression. Moreover, the ability to produce EM1 in recombinant systems paves the way for large-scale production, making it possible to conduct high-throughput screenings for drug discovery and development. Recent advancements in techniques like CRISPR and synthetic biology have further accelerated the manipulation and optimization of EM1, enhancing its stability and efficacy. Overall, the exploration of EM1 recombinant protein not only enriches our understanding of fundamental biological processes but also contributes to the development of innovative therapeutic strategies for complex diseases.
